Upregulation of CCT3 promotes cervical cancer progression through FN1

Dou,Lei; Zhang,Xinxin

doi:10.3892/mmr.2021.12496

Upregulation of CCT3 promotes cervical cancer progression through FN1

Authors:
- Lei Dou
- Xinxin Zhang
View Affiliations

Affiliations: Department of Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China, Department of Discipline Inspection Commission, China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: October 14, 2021 https://doi.org/10.3892/mmr.2021.12496
Article Number: 856
Copyright: © Dou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The mechanisms underlying cervical cancer progression have not yet been fully elucidated; thus, further investigations are required. Chaperonin containing TCP1 subunit 3 (CCT3) expression was found to be upregulated in several types of human cancer. However, the roles of CCT3 in cervical cancer remain poorly understood. Thus, the present study aimed to determine the roles of CCT3 in the progression of cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). For this purpose, the Tumor Immune Estimation Resource and Gene Expression Profiling Interactive Analysis databases were used to analyze the mRNA and protein expression levels of CCT3 in CESC samples. The effects of CCT3 on the proliferation and migration of CESC in vitro were determined using various experiments, including proliferation, Transwell and flow cytometric assays. The results revealed that CCT3 expression was significantly upregulated in CESC, which was associated with a poor prognosis. The silencing of CCT3 suppressed CESC cell proliferation, migration and invasiveness in vitro. Additionally, CCT3‑knockdown promoted CESC cell apoptosis and cell cycle arrest, and suppressed fibronectin 1 (FN1) protein expression. Furthermore, rescue assays demonstrated that CCT3 promoted CESC proliferation and migration via FN1. In conclusion, the findings of the present study demonstrated that CCT3 is closely associated with the progression of CESC. Thus, CCT3 may be considered a novel, promising biomarker, and a possible therapeutic target for CESC.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Zhang X, Li F and Zhu L: Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer. Life Sci. 209:242–248. 2018. View Article : Google Scholar : PubMed/NCBI
3	Zhu X, Zhou L, Li R, Shen Q, Cheng H, Shen Z and Zhu H: AGER promotes proliferation and migration in cervical cancer. Biosci Rep. 38:BSR201713292018. View Article : Google Scholar : PubMed/NCBI
4	Zhu H, Shen Z, Luo H, Zhang W and Zhu X: Chlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-Analysis. Medicine (Baltimore). 95:e30772016. View Article : Google Scholar : PubMed/NCBI
5	Zhu H, Luo H, Shen Z, Hu X, Sun L and Zhu X: Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer. Tumour Biol. 37:7075–7083. 2016. View Article : Google Scholar : PubMed/NCBI
6	Yang Z, Sun Q, Guo J, Wang S, Song G, Liu W, Liu M and Tang H: GRSF1-mediated MIR-G-1 promotes malignant behavior and nuclear autophagy by directly upregulating TMED5 and LMNB1 in cervical cancer cells. Autophagy. 15:668–685. 2019. View Article : Google Scholar : PubMed/NCBI
7	Lin YF, Tsai WP, Liu HG and Liang PH: Intracellular beta-tubulin/chaperonin containing TCP1-beta complex serves as a novel chemotherapeutic target against drug-resistant tumors. Cancer Res. 69:6879–6888. 2009. View Article : Google Scholar : PubMed/NCBI
8	Vallin J and Grantham J: The role of the molecular chaperone CCT in protein folding and mediation of cytoskeleton-associated processes: Implications for cancer cell biology. Cell Stress Chaperones. 24:17–27. 2019. View Article : Google Scholar : PubMed/NCBI
9	Klimczak M, Biecek P, Zylicz A and Zylicz M: Heat shock proteins create a signature to predict the clinical outcome in breast cancer. Sci Rep. 9:75072019. View Article : Google Scholar : PubMed/NCBI
10	Park SH, Jeong S, Kim BR, Jeong YA, Kim JL, Na YJ, Jo MJ, Yun HK, Kim DY, Kim BG, et al: Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer. Oncogene. 39:136–150. 2020. View Article : Google Scholar : PubMed/NCBI
11	Wang L, Zhao H, Li J, Xu Y, Lan Y, Yin W, Liu X, Yu L, Lin S, Du MY, et al: Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines. Oncogene. 39:677–689. 2020. View Article : Google Scholar : PubMed/NCBI
12	Liu P, Kong L, Jin H, Wu Y, Tan X and Song B: Differential secretome of pancreatic cancer cells in serum-containing conditioned medium reveals CCT8 as a new biomarker of pancreatic cancer invasion and metastasis. Cancer Cell Int. 19:2622019. View Article : Google Scholar : PubMed/NCBI
13	Liu Y, Zhang X, Lin J, Chen Y, Qiao Y, Guo S, Yang Y, Zhu G, Pan Q, Wang J, et al: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. Cell Death Dis. 10:6442019. View Article : Google Scholar : PubMed/NCBI
14	Qian EN, Han SY, Ding SZ and Lv X: Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma. Cancer Cell Int. 16:552016. View Article : Google Scholar : PubMed/NCBI
15	Shi X, Cheng S and Wang W: Suppression of CCT3 inhibits malignant proliferation of human papillary thyroid carcinoma cell. Oncol Lett. 15:9202–9208. 2018.PubMed/NCBI
16	Cui F, Hu J, Fan Y, Tan J and Tang H: Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer. Oncol Lett. 15:5712–5720. 2018.PubMed/NCBI
17	Wan X, Pu H, Huang W, Yang S, Zhang Y, Kong Z, Yang Z, Zhao P, Li A, Li T, et al: Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy. Oncotarget. 7:51284–51300. 2016. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et al: Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar : PubMed/NCBI
20	Thomas A, Mahantshetty U, Kannan S, Deodhar K, Shrivastava SK, Kumar-Sinha C and Mulherkar R: Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease. Cancer Med. 2:836–848. 2013. View Article : Google Scholar : PubMed/NCBI
21	Scotto L, Narayan G, Nandula SV, Arias-Pulido H, Subramaniyam S, Schneider A, Kaufmann AM, Wright JD, Pothuri B, Mansukhani M, et al: Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression. Genes Chromosomes Cancer. 47:755–765. 2008. View Article : Google Scholar : PubMed/NCBI
22	Xu G, Bu S, Wang X, Zhang H and Ge H: Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells. Cancer Cell Int. 20:2182020. View Article : Google Scholar : PubMed/NCBI
23	Dun MD, Smith ND, Baker MA, Lin M, Aitken RJ and Nixon B: The chaperonin containing TCP1 complex (CCT/TRiC) is involved in mediating sperm-oocyte interaction. J Biol Chem. 286:36875–36887. 2011. View Article : Google Scholar : PubMed/NCBI
24	Nadler-Holly M, Breker M, Gruber R, Azia A, Gymrek M, Eisenstein M, Willison KR, Schuldiner M and Horovitz A: Interactions of subunit CCT3 in the yeast chaperonin CCT/TRiC with Q/N-rich proteins revealed by high-throughput microscopy analysis. Proc Natl Acad Sci USA. 109:18833–18838. 2012. View Article : Google Scholar : PubMed/NCBI
25	Syed A, Lukacsovich T, Pomeroy M, Bardwell AJ, Decker GT, Waymire KG, Purcell J, Huang W, Gui J, Padilla EM, et al: Miles to go (mtgo) encodes FNDC3 proteins that interact with the chaperonin subunit CCT3 and are required for NMJ branching and growth in Drosophila. Dev Biol. 445:37–53. 2019. View Article : Google Scholar : PubMed/NCBI
26	Yao L, Zou X and Liu L: The TCP1 ring complex is associated with malignancy and poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 12:3329–3343. 2019.PubMed/NCBI
27	Carr AC, Khaled AS, Bassiouni R, Flores O, Nierenberg D, Bhatti H, Vishnubhotla P, Manuel JP, Santra S and Khaled AR: Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer. Oncotarget. 8:110273–110288. 2017. View Article : Google Scholar : PubMed/NCBI
28	Qiu X, He X, Huang Q, Liu X, Sun G, Guo J, Yuan D, Yang L, Ban N, Fan S, et al: Overexpression of CCT8 and its significance for tumor cell proliferation, migration and invasion in glioma. Pathol Res Pract. 211:717–725. 2015. View Article : Google Scholar : PubMed/NCBI
29	Nibbe RK, Markowitz S, Myeroff L, Ewing R and Chance MR: Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics. 8:827–845. 2009. View Article : Google Scholar : PubMed/NCBI
30	Wang J, Deng L, Huang J, Cai R, Zhu X, Liu F, Wang Q, Zhang J and Zheng Y: High expression of Fibronectin 1 suppresses apoptosis through the NF-κB pathway and is associated with migration in nasopharyngeal carcinoma. Am J Transl Res. 9:4502–4511. 2017.PubMed/NCBI
31	Li B, Shen W, Peng H, Li Y, Chen F, Zheng L, Xu J and Jia L: Fibronectin 1 promotes melanoma proliferation and metastasis by inhibiting apoptosis and regulating EMT. OncoTargets Ther. 12:3207–3221. 2019. View Article : Google Scholar : PubMed/NCBI
32	Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S, Krogerus L, Heikkilä P, von Smitten K, Saksela O, et al: Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. Am J Pathol. 177:387–403. 2010. View Article : Google Scholar : PubMed/NCBI
33	Cai X, Liu C, Zhang TN, Zhu YW, Dong X and Xue P: Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion. J Cell Biochem. 119:4717–4728. 2018. View Article : Google Scholar : PubMed/NCBI
34	Yang X, Hu Q, Hu LX, Lin XR, Liu JQ, Lin X, Dinglin XX, Zeng JY, Hu H, Luo ML, et al: miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1. Discov Med. 24:75–85. 2017.PubMed/NCBI
35	Wang Y, Huang L, Wu S, Jia Y, Yang Y, Luo L, Bi A and Fang M: Bioinformatics analyses of the role of vascular endothelial growth factor in patients with non-small cell lung cancer. PLoS One. 10:e01392852015. View Article : Google Scholar : PubMed/NCBI
36	Balasubramaniam SD, Balakrishnan V, Oon CE and Kaur G: Key molecular events in cervical cancer development. Medicina (Kaunas). 55:3842019. View Article : Google Scholar : PubMed/NCBI
37	Nero C, Ciccarone F, Pietragalla A and Scambia G: PTEN and Gynecological cancers. Cancers (Basel). 11:14582019. View Article : Google Scholar : PubMed/NCBI